U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07481539) titled 'Subcutaneous Piperacillin/Tazobactam Compared With Intravenous Treatment' on March 09.
Brief Summary: The goal of this clinical trial is to learn whether subcutaneous piperacillin/tazobactam can provide drug exposure similar to standard intravenous piperacillin/tazobactam in adults who need treatment for an infection. It will also assess safety and clinical outcomes. The main questions it aims to answer are:
* Does subcutaneous piperacillin/tazobactam achieve pharmacokinetic exposure comparable to intravenous treatment?
* Is subcutaneous piperacillin/tazobactam safe and feasible in this population? Researchers will compare subcut...